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ABSTRACT
NAG2-967
The exposure of the body to microgravity during space flight causes a series of well-
documented changes in Ca 2+ metabolism, yet the cellular/molecular mechanisms leading to these
changes are poorly understood. There is some evidence for microgravity-induced alterations in
the vitamin D endocrine system, which is known to be primarily involved in the regulation of
Ca 2÷ metabolism. Vitamin D-dependent Ca 2÷ binding proteins, or calbindins, are believed to
have a significant role in maintaining cellular Ca 2÷ homeostasis.
We used immunocytochemical, biochemical and molecular approaches to analyze the
expression of calbindin-Daak and calbindin-Dgk in kidneys and intestine of rats flown for 9 days
aboard the Spacelab 3 mission. The effects of microgravity on calbindins in rats in space vs.
"grounded" animals (synchronous Animal Enclosure Module controls and tail suspension
controls) were compared. Exposure to microgravity resulted in a significant decrease in
calbindin-D28k content in kidneys and calbindin-Dgk in the intestine of flight and suspended
animals, as measured by enzyme-linked immunosorbent assay (ELISA). Immunocytochemistry
(ICC) in combination with quantitative computer image analysis was used to measure in situ the
expression of calbindins in kidneys and intestine, and insulin in pancreas. There was a large
decrease in the distal tubular cell-associated calbindin-D2sk and absorptive cell-associated
calbindin-D9k immunoreactivity in the space and suspension kidneys and intestine, as compared
with matched ground controls. No consistent differences in pancreatic insulin immunoreactivity
between space, suspension and ground controls was observed. There were significant correlations
between results by quantitative ICC and ELISA. Western blot analysis showed no consistent
changes in the low levels of intestinal and renal vitamin D receptors.
These findings suggest that a decreased expression of calbindins after a short-term
exposure to microgravity and modelled weightlessness, may affect cellular Ca 2+ homeostasis and
contribute to Ca 2÷ and bone metabolism disorders induced by space flight.
INTRODUCTION
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Vitamin D is the precursor of the steroid hormone, 1,25-dihydroxyvitamin D 3 [ 1,25(OH)2D3]
(Norman et al., 1982; Henry and Norman, 1984; Sergeev, 1989). 1,25(OH)2D3 produces a wide
spectrum of biological effects via both receptor mediated regulation of nuclear events (Minghetti
and Norman, 1988; Lowe et al., 1992) and rapid actions independent of the genomic pathway
(Norman et al., 1992; Farach-Carson et al., 1991; Sergeev and Rhoten, 1995). The vitamin D
receptor (VDR) regulates genes associated with Ca 2÷ homeostasis (e.g., calbindins; Christakos
et al., 1984), with the proliferation pathway, the differentiation pathway and the developmental
cascade (Lowe et al., 1992). Calbindins are believed to be essential, as intracellular Ca 2÷
sequestrants/buffers, to the process of intestinal Ca 2÷ absorption (Nemere et al., 1991; Norman
et al., 1992) and renal Ca/+ reabsorption (Johnson and Kumar, 1994; Hemmingsen et al., 1995).
Calbindin-Dzsk, functioning as an intracellular Ca 2÷ buffer, is crucial for preventing accumulation
of excessive levels ofcytosolic free Ca 2÷ (Iacopino et al., 1992; Rhoten and Sergeev, 1994) and,
thus, determining cell fate (Dowd, 1995).
There is the evidence that the integrated operation of the vitamin D endocrine system is
affected by factors of space flight, including evidence from human and rat models of
microgravity (Arnaud et al., 1991; Morey-Holton et al., 1988; Sergeev et al., 1982-1986;
Spirichev and Sergeev, 1988). Serum 1,25(OH)2D3 concentration decreased in healthy volunteers
after one year bed rest with the head lower than the feet (Sergeev and Morukov, unpublished
observations). The 1,25(OH)2D3 production in the kidney and accumulation of the hormone in
the bone and intestine markedly decreased in rats after long-term hypokinesia (Sergeev et al.,
1983; 1984). These were accompanied by a decrease in the intestinal Ca 2÷ absorption (Sergeev
and Spirichev, 1987) and osteopenia (Kabitskaya et al., 1984; Sergeev et al., 1987). Prophylactic
treatment with vitamin D 3 active metabolites prevented bone loss to a significant extent in rats
during long-term hypokinesia (Sergeev et al., 1982a,b, 1985, 1987; Ushakov et al., 1982,
1983a,b, 1984), indicating a crucial role for the vitamin D endocrine system in regulation of
bone and Ca z÷ metabolism in modeled weightlessness.
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The phenomenology of possible changes in vitamin D-mediated biological responses
(e.g., calbindins) during and after space flights remains currently unknown. It seems probable
that the vitamin D hormone-mediated regulation, particularly that of calbindins, may be a critical
factor in adaptational and readaptational changes of at least Ca 2÷ metabolism under the action
of weightlessness/gravity.
We participated in the organ sharing program for tissues from rats flown aboard the
Spacelab 3 mission and compared the effects of microgravity on calbindins in rats in space vs.
"grounded" animals (synchronous Animal Enclosure Module, tail suspension, and vivarium
controls). We hypothesized that exposure to microgravity might affect expression of vitamin D-
dependent calcium binding proteins, calbindin-DEsk and calbindin-D9k. To test this hypothesis we
evaluated the following parameters in the kidney and intestine: 1) calbindin-D2ak and calbindin-
D9k contents; 2) immunocytochemical expression of calbindin-DEsk and calbindin-D9k; 3) the level
of vitamin D receptors.
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MATERIALS AND METHODS
Sample handling
Male Sprague-Dawley rats (weighing ca. 150 g and aged 6 wk at launch) were flown for
9 days aboard the Spacelab 3 mission. Upon return to earth, the animals were dissected within
"zero", 24 and 72 h post-flight (groups FRO, FR24, and FR72). Age- and sex-matched ground
control animals were maintained in the Animal Enclosure Module (AEM) where factors of the
space flight, except microgravity, were synchronously reproduced (groups FCR0, FCR24, and
FCR72). Tail suspension rats were used as a model which mimics some effects of microgravity
(groups SynSuspR0, SynSuspR24, and SynSuspR72); corresponding controls for these animals
were rats kept in the vivarium (SynVivR0, SynVivR24, and SynVivR72). Moreover, the pre-
flight, basal control group (VivL0) was dissected before launch.
The organs (right kidney and the washed upper portion of the small intestine ca. 10 cm
in length) were snap-frozen in liquid nitrogen, stored at -70°C and shipped to the laboratory on
dry ice. Left kidney, duodenum and pancreas were fixed in formalin.
Enzyme-linked immunosorbent assay
Calbindin-D28k and calbindin-D9k in kidneys and calbindin-Dgk in intestine were measured by
means of an enzyme-linked immunosorbent assay (ELISA), as described previously (Miller and
Norman, 1983; Rhoten and Sergeev, 1994). Diluted cytosol aliquots (50 _tL; 0.5 mg/mL total
protein of kidney cytosol for calbindin-D28k, 0.1 mg/mL total protein of kidney cytosol for
calbindin-Dgk, and 0.1 mg/mL total protein of intestinal cytosol for calbindin-D9k) were assayed
in calbindin-D28k-coated (10 ng/well) or calbindin-Dgk-Coated (2.5 ng/well) multiwell flat
bottomed immunoassay plates. Chicken intestinal calbindin-D28k was a gift from Dr. A.W.
Norman (University of California-Riverside), and bovine intestinal calbindin-Dgk was purchased
from Sigma (St. Louis, MO). Calbindin-coated plates were washed and preblocked with 1%
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bovine serum albumin, 0.5 % Tween 20 in phosphate buffered saline (PBS), and then incubated
for 2 h at room temperature with unknown, standards (0 - 400 ng calbindin-D/sk/Well or 0 - 12.5
ng calbindin-Dgk/well) and primary antibody (150 #L; mouse monoclonal anti-calbindin-D2sk,
clone CL-300, Sigma, 1:140,000 dilution, or rabbit antiserum against calbindin-D9k, 1:5,000
dilution, a gift from Dr. M.E. Bruns). The washed plates were then incubated for 2 h with a
secondary antibody (alkaline phosphatase labeled goat anti-mouse or anti-rabbit IgG, 1:1,500
dilution, Sigma). Substrate, p-nitro-phenylphosphate (1 mg/mL in diethanolamine buffer, pH
9.8), was used to produce a chromogen which was quantitated at 405 nm in the microplate
reader. Protein concentration in cytosols was measured with a Bio-Rad detergent-compatible
protein microassay (Bio-Rad Laboratories, Hercules, CA), using a microplate format.
Immunocytochemistry
Cellular localization and quantification of calbindin-D28k in kidneys, calbindin-D9k in
duodenum, and insulin in pancreas was carried out on the formalin-fixed tissues, as described
previously (Rhoten et al., 1985; Rhoten, 1987; Rhoten and Christakos, 1990). Fixed tissues were
embedded in Paraplast (Monoject Scientific, St. Louis, MO). Microtome sections were affixed
to Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA) and stored at room
temperature until use. Paraffin was removed and sections rehydrated. Slides were treated with
3% H202 in PBS for 10 min, rinsed in PBS, and then incubated overnight in a humid chamber
at 4°C with primary antibody. The antibodies used were mouse anti-calbindin-DEsk, clone CL-
300, 1:200 dilution in Tris buffered saline, pH 7.6, containing 2% normal goat serum, and 1%
albumin (SA-TBS); rabbit anti-rat intestinal calbindin-D9k, 1:400 dilution in SA-TBS; and guinea
pig anti-insulin, 1:200 dilution in SA-TBS. Slides were then washed with SA-TBS, and primary
antibodies detected using goat peroxidase labeled anti-mouse IgG, 1:100 dilution (Sigma); goat
peroxidase labelled anti-rabbit IgG, 1:100 dilution (Incstar, Stillwater, MN); and rat peroxidase
labelled anti-guinea pig IgG, 1:200 dilution (Sigma). Slides were incubated with secondary
antibodies for 45 min at room temperature. Chromogen used was 3,3'-diaminobenzidine.
In situ levels of the calbindins and insulin were quantified on the basis of the intensity
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of the oxidized diaminobenzidine reaction product present in individual cells, using an Image-1
image acquisition, processing and analysis system (Universal Imaging, West Chester, PA).
Labeling intensity (brightness) was measured on digitized images in arbitrary O.D. units based
on a 255 tone gray scale, where the value of zero is completely black and 255 is completely
white (transparent). The intensity value encompassed both the number of labeled cells and their
individual brightness values, and was obtained by defining the outline of the cell cluster and
determining the average brightness value over the entire area. The same defined area was placed
on the image close to the measured positive (darker) area to determine the level of background
non-specific staining. Data are expressed as relative labeling intensity in %, i.e., (brightness of
the positive area)/(brightness of the background area) X 100, so that lower (i. e, more dense)
numbers correspond to higher levels of calbindins. For each stained slide, 2 - 3 fields of cells
were captured and at least three areas of labeled cells were counted.
Western blot analysis
Vitamin D receptors in the intestine and kidney were detected using Western blot technique.
Tissues were thawed on ice, intestinal mucosa was scraped, and homogenates (20% wt/vol) in
a high-ionic-strength buffer (KTED: 300 mM KC1, 10 mM Tris, pH 7.4, 1.5 mM EDTA, 5.0
mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride) were prepared (Sergeev and Norman,
1992; Norman et al., 1993). The cytosol fraction of homogenates (35,000 g, 1 h, 4°C) was used
for Western blot analysis.
The cytosol aliquots (150/_g protein) were subjected to SDS-polyacrylamide (12%) gel
electrophoresis and transfered to nitrocellulose sheets using a Bio-Rad transfer unit. The sheets
were preblocked with 5 % non-fat milk in PBS and then probed with rat monoclonal anti-VDR
antibodies (1:500 dilution, 2 h at room temperature) (Affinity BioReagents, Golden, CO). The
bands were visualized with alkaline phosphatase labeled secondary antibodies (anti-rat IgG,
Sigma) for 1 h at room temperature. Chromogen used was BCIP/NBT.
For Western blot analysis ofcalbindin-D2ak, kidney cytosols were subjected to SDS-PAGE,
transfer and blocking, as described for VDRs. The nitrocellulose sheets were probed with mouse
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monoclonal anti-calbindin-D28k (1:200 dilution, 2 h at room temperature), and the bands were
visualized with alkaline phosphatase labeled secondary antibodies (anti-mouse IgG, Sigma)
(Mutema and Rhoten, 1994).
In Western blot analysis of B-actin, primary antibodies used were mouse monoclonal anti-
_-actin (Clone Ac-15, 1:1000 dilution; Sigma) and secondary antibodies were alkaline
phosphatase labeled anti-mouse IgG (1:1000 dilution; Sigma).
Statistics
Statistical analysis of the data was performed using Sigma Stat v. 1.0 software (Jandel
Scientific, San Rafael, CA).
RESULTS
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Measurement of calbindin-D2sk and calbindin-D9k in kidneys and calbindin-D9_ in intestine
by ELISA
ELISA was used to measure total calbindin contents in kidneys and the intestinal mucosa
of space, suspension and ground animals. Calbindin contents varied among the individual
animals (see Appendix). However, when data were pooled and normalized per mg protein, the
calbindin-DE8k content in kidneys and calbindin-D9k content in the intestine of space and
suspension animals proved to be significantly reduced compared with ground control animals
(Fig. 1). In terms of the flight groups, this decrease was 24.0, 23.9 and 23.5% for calbindin-
D28k in kidneys at "zero", 24 and 72 h post-flight, respectively (see also Fig. 1, left panel) ; for
calbindin-D9k in the intestine the decrease was 57.8, 19.2 and 47.3% at "zero", 24 and 72 h
post-flight (see also Fig. 1, middle panel). Quantitatively similar decreases were revealed when
synchronous suspension and vivarium groups were compared at "zero", 24 and 72 h post-flight
(see Fig. 1).
The content of calbindin-D9k in kidneys was very low, as compared with the calbindin-
D28 k content (in ng/mg protein range vs. #g/mg protein range for calbindin-Dzsk) (Fig. 1, right
panel). An apparent decrease in the renal calbindin-Dgk of suspension animals at "zero" and 72
h, but not 24 h post-flight was observed. This trend was statistically significant for FRO vs.
FCRO groups.
In situ quantification of calbindin-D28k in kidneys, calbindin-D9k in intestine and insulin
in pancreas using immunocytochemistry
Immunocytochemistry (ICC) in combination with quantitative computer image analysis
was used to measure in situ the expression of calbindins in kidneys and intestine, and insulin in
pancreas. The predominate immunolocalization of renal calbindin-D28k in all animals was similar
to that first reported by us (Rhoten and Christakos, 1981), i.e., cells of distal convoluted
tubules, connecting tubules and cortical collecting tubules. Some flight and grounded animals
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had kidneys exhibiting a highly variable amount of immunoreactivity for calbindin-D28k in the
medullary collecting ducts and papillary ducts. The absence of consistent immunolocalization in
medullary collecting ducts and papillary ducts argued against quantifying the calbindin-D28k found
in these sites. Intestinal localization of calbindin-D9k appeared to be confined to the absorptive
cells. As seen in Fig. 2, there was a large decrease in the distal tubular cell-associated calbindin-
D28 k immunoreactivity and in the absorptive cell-associated calbindin-D9k immunoreactivity in
the space kidneys and intestine, as compared with matched ground control animals. Insulin was
localized to relatively large numbers of cells making up the core of pancreatic islets. A result
consistent with the localization of insulin in fl-cells of the rat. There was no consistent difference
in pancreatic insulin immunoreactivity of space and ground animals (see Fig. 2). No specific
immunoreactivity for calbindin-DEsk was observed in the pancreatic islet cells of any of the flight
or grounded animals.
Summary of quantitative image analysis of tissues from space, suspension and ground
animals are presented in Fig. 3. Comparison of groups was done as described above for ELISA.
Reductions in the calbindin-D28k level in kidneys and the calbindin-D9k level in the intestine were
similar to those found with ELISA (see Fig. 3, left and middle panels). Linear regression
analysis of data obtained using ELISA and quantitative ICC, showed a statistically significant
correlation between two methods (Fig. 4). Insulin level in pancreas varied widely among animals
within a group, and no apparent trend to the decreased insulin immunoreactivity was revealed
in space and suspension animals (see Fig. 3, right panel).
Detection of vitamin D receptors in the intestine and kidneys using Western blot analysis
VDR levels in kidneys and the intestinal mucosa of flight and flight control animals were
compared using Western blotting with rat monoclonal anti-VDR antibodies. As seen on
representative immunoblots (Fig. 5), there were no consistent changes in the VDR level, based
on the intensity of specific bands. Importantly, there was also no changes in the intestinal fl-actin
level. Calbindin-D28k levels, measured on some of the same membranes, varied in the same way
as seen quantitatively by ELISA.
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Fig. 2. Immunocytochemical localization and quantification of calbindins and insulin. Tissue
sections were immunoreacted and calbindin-D28 k in kidney (p. 12), calbindin-Dgk in the
intestine (p. 13), and insulin in pancreas (p. 14) were measured, as described in Materials and
Methods. Scale marker = 50/zm (kidneys, pancreas) or 100 #m (intestine).
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Fig. 5. Western blot analysis of VDRs and calbindins in the intestine and kidneys of space and
ground animals. The cytosol extracts of the intestinal mucosa and kidneys were subjected to
SDS-PAGE and immunoblotting, as described in Materials and Methods. Protein standards of
the indicated molecular masses (K) were run in a parallel lane. CNTR = cytosol extract of
MDBK cells which have lower levels of the VDR expression, as compared with rat tissues.
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Calcium metabolism and its regulation change promptly (within days) with exposure of
the body to microgravity or simulated weightlessness (hypokinesia, suspension) (Arnaud and
Morey-Holton, 1989; Spirichev and Sergeev, 1988). The vitamin D hormone, 1,25(OH)2D3, is
the critical component of the Ca2+-regulating endocrine system (Norman et al., 1982, 1992).
Vitamin D-dependent Ca2+-binding proteins, calbindin-D28k and calbindin-Dgk, play the essential
roles in the regulation of Ca 2+ metabolism and maintenance of cellular Ca 2+ homeostasis.
Calbindins are involved in the intestinal Ca 2+ absorption, renal Ca z+ reabsorption, and
intracellular Ca 2+ buffering (Christakos et al., 1989; Rhoten and Sergeev, 1994; Johnson and
Kumar, 1994).
In this study, we have demonstrated, using two independent approaches, a significant
decrease in the renal calbindin-D28k and intestinal calbindin-Dgk content and immunocytochemical
expression in rats exposed for 9 days to microgravity on board the Spacelab 3 mission.
Importantly, suspension animals demonstrated virtually identical changes in calbindins. These
findings strongly suggest that factors of modelled weightlessness (suspension) can mimic the
effects of microgravity on calbindins.
Because calbindins are vitamin D-regulated proteins and because VDRs seem to be not
affected by the factors of space flight, the decreased circulating concentration of the hormonal
form of vitamin D, 1,25(OH)2D 3, might be primarily responsible for the reduction in calbindin
contents and levels of expression in kidneys and intestine of flight and suspension animals.
Decreased production of 1,25(OH)2D3 in kidneys may determine, to a large extent, such
reduction in the serum 1,25(OH)2D 3 concentration. As we have shown earlier, this is the case
for hypokinetic model of weightlessness in rats (Sergeev et al., 1984; Spirichev and Sergeev,
1988).
The depression of calbindin-D28k in kidneys and calbindin-Dgk in the intestine appears to
be relatively selective, because 13-actin level in the intestine and insulin level in the pancreas,
evaluated by Western blot analysis and ICC respectively, were not changed in space and
18
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suspension animals.
It is also noteworthy, that the decrease in calbindins was independent of the time of
harvesting the tissues after reentry. This suggests that the reduction in amounts of calbindins and
gene expression for these calcium-binding proteins is a long-lasting effect of microgravity and
suspension per se, rather than a rapid, transient stress response.
Functional consequences of decreased calbindin expression, at the organismal level, might
be the decreased absorption of Ca z+ in the intestine, increased excretion of Ca 2+ in the urine,
and, at the cellular level, the sustained increase in the concentration of cytosolic free Ca 2+,
which may interfere with Ca 2+ signaling and cause an increase in the rate of cell death.
Thus, our study implies that the decrease of calbindin contents and immunocytochemical
expressions in kidneys and intestine from rats exposed to microgravity and modelled
weightlessness (tail suspension) may be directly related to changes in Ca 2+ metabolism under the
effects of these conditions. Changes in calbindins may be attributed to an interference of
microgravity and suspension with functioning of the vitamin D-endocrine system. Future space
and ground-based experiments are necessary to test this hypothesis.
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CONCLUSIONS
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Content and immunocytochemical expression of calbindin-D28k in kidney and calbindin-
Dqk in the intestine were decreased in flight vs. flight control animals and in tail suspension vs.
vivarium controls at "zero", 24 and 72 h post-flight. Decrease in renal calbindin-DEsk and
intestinal calbindin-D9k may affect Ca 2÷ handling in these organs; namely, it may be partly
responsible for the increased Ca 2+ excretion in the urine and decreased Ca 2+ absorption in the
small intestine observed after a short-term space flight and modelled weightlessness.
No consistent changes in the low levels of intestinal and renal VDRs of flight animals
were found with Western blot analysis, implying that decreased circulating concentration of
1,25(OH)2D3 in space flight and modelled weightlessness might reduce the calbindin expression
in these tissues.
Factors of space flight and modelled weightlessness had no apparent effect on the
immunocytochemical expression of insulin in pancreas.
Our findings suggest that the decreased expression of calbindins after a short-term
exposure to microgravity and modelled weightlessness may affect cellular Ca 2÷ homeostasis and
contribute to Ca 2÷ and bone metabolism disorders induced by space flight.
20
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This investigation has allowed us to assess the effects of short-term space flight on
calbindins and their regulation by the vitamin D endocrine system. Assessment included the
application of a new method for quantifying calbindins at the single cell level. This technically
significant advance should be utilized in future studies on cells, tissues and organs in altered
gravity states. The results contribute to our understanding of the genesis of space flight-induced
disorders of Ca 2÷ metabolism.
Future space and ground-based experiments are necessary to study functional
consequences of the decreased expression of calbindins at the cellular level and to investigate
whether up-regulation of calbindins, e.g., with analogs of the vitamin D hormone will be useful
for prevention of disorders of Ca 2÷ metabolism induced by space flight.
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Calbindin-D28k, Kidney, ELISA
Descriptive Statistics:
Column Size Mean
VivCL0 6 7.38
FCR0 6 5.92
FCR24 5 7.29
FCR72 5 6.29
FRO 6 4.50
FR24 5 5.55
FR72 5 4.81
SynVivR0 6 7.37
SynVivR24 5 7.45
SynVivR72 5 7.62
SynSuspR0 ii 3.93
SynSuspR24 5 4.84
SynSuspR72 5 3.66
Column Std Dev Std. Error
VivCL0 0.961 0.392
FCR0 0.943 0.385
FCR24 0.639 0.286
FCR72 0.645 0.289
FRO 0.925 0.378
FR24 0.876 0.392
FR72 0.980 0.438
SynVivR0 0.913 0.373
SynVivR24 0.884 0.395
SynVivR72 1.256 0.562
SynSuspR0 0.748 0.225
SynSuspR24 1.028 0.460
SynSuspR72 0.822 0.367
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SynSuspR24
SynSuspR72
Max
9 01
7 78
7 92
6 83
6 01
6 65
6 26
8 69
8.44
9.60
4.95
6.25
4.51
Min
6.33
5.26
6.33
5.25
3.28
4.57
3.67
5.94
6.10
6.40
2.17
3.42
2.34
Range
2.69
2.52
1.59
1 59
2 73
2 08
2 59
2 75
2 35
3 20
2 78
2 83
2 17
Median
7.01
5.65
7.33
6.53
4.51
5.76
4.97
7.38
7.37
7.47
4.00
4.79
3.83
A1
Calbindin-D9k, Intestine, ELISA
Descriptive Statistics:
Column Size
VivCL0 6
FCR0 6
FCR24 5
FCR72 5
FRO 6
FR24 5
FR72 5
SynVivR0 6
SynVivR24 5
SynVivR72 5
SynSuspR0 ii
SunSuspR24 5
SynSuspR72 5
Column Std Dev
VivCL0 0.563
FCR0 0.271
FCR24 0.215
FCR72 0.438
FRO 1.115
FR24 1.264
FR72 0.703
SynVivR0 0.632
SynVivR24 0.367
SynVivR72 0.224
SynSuspR0 0.651
SunSuspR24 0.728
SynSuspR72 1.428
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SunSuspR24
SynSuspR72
Max
5.06
5 50
4 75
5 14
3 71
4 33
3 08
5 36
5 52
5 43
2 99
3 94
3 79
Mean
4 46
5 19
4 43
4 46
2 19
3 58
2 35
4 42
5.05
5.12
2.01
3.40
1.89
Std. Error
0.2299
0.1106
0.0960
0.1958
0.4552
0.5652
0.3146
0.2582
0.1641
0.i001
0.1962
0.3257
0.6387
Min
3.618
4.833
4.157
3.926
0.895
1.335
1.302
3.535
4.591
4.866
0.730
2.204
0.315
Range
1 447
0 665
0 594
1 216
2 811
2 992
1 777
1 821
0 924
0 561
2 261
1 733
3 473
Median
4.54
5.26
4.45
4.40
2.09
4.13
2.62
4.38
4.99
5.12
2.02
3.78
2.13
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A2
Calbindin-D9k, Kidney, ELISA
Descriptive Statistics:
Column Size
VivCL0 6
FCR0 6
FCR24 5
FCR72 5
FRO 6
FR24 5
FR72 5
SynVivR0 6
SynVivR24 5
SynVivR72 5
SynSuspR0 ii
SunSuspR24 5
SynSuspR72 3
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SunSuspR24
SynSuspR72
Std Dev
2.55
4.82
7.71
7.15
7 51
4 36
4 37
ii 32
3 95
ii 52
7 16
ii 96
6 50
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SunSuspR24
SynSuspR72
Max
40
33
29
30
29
29
25
48
37
44
27
40
25
Mean
35 9
26 1
18 9
24 3
15 7
26 1
19 1
30.4
32.6
24.5
19.2
26.3
18.2
Std. Error
1.04
1.97
3.45
3.20
3 07
1 95
1 95
4 62
1 76
5 15
2 16
5 35
3 75
Min
33.78
18.59
10.99
14.48
9.04
19.15
14.41
17.19
27.30
15.59
6.11
13.78
13.92
Range
6.90
15.19
17.98
15.68
20.49
10.66
11.29
31.30
10.46
28.37
21.47
26.42
11.78
Median
35.5
26.3
21.3
29.0
13.8
28.5
17.7
31.3
33.5
21.7
23.3
31.2
15.0
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A3
Calbindin-D28k, Kidney, ICC
Descriptive Statistics:
Column Size Mean
FCR0 102 42.4
FCR24 50 20.9
FCR72 50 28.5
FRO 119 63.0
FR24 50 38.0
FR72 50 39.3
SynVivR0 42 37.4
SynVivR24 50 40.4
SynVivR72 50 39.4
SynSuspR0 170 59.1
SynSuspR24 50 52.3
SynSuspR72 49 64.7
Column Std Dev Std. Error
FCR0 11.60 1.222
FCR24 6.68 0.996
FCR72 8.26 1.232
FR0 13.09 1.260
FR24 11.08 1.651
FR72 10.34 1.541
SynVivR0 10.47 1.745
SynVivR24 5.51 0.822
SynVivR72 5.86 0.874
SynSuspR0 8.83 0.714
SynSuspR24 6.05 0.902
SynSuspR72 7.01 1.058
Column Max
FCR0 63
FCR24 37
FCR72 52
FRO 88
FR24 63
FR72 64
SynVivR0 60
SynVivR24 51
SynVivR72 48
SynSuspR0 79
SynSuspR24 65
SynSuspR72 78
Min
22 77
9 58
16 74
32 83
15 18
21 82
24 15
25 84
21 82
35 33
41 44
46.30
Range
40.9
28.2
35 3
55 7
48 0
42 3
35 8
25 8
26 8
43 8
23 7
31 8
Median
38.8
19.3
27.4
61.1
36.9
38.6
32.8
39.9
41.2
58.5
51.0
66.2
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A4
Calbindin-D9k, Intestine, ICC
Descriptive Statistics:
Column Size
FCR0 28
FCR24 21
FCR72 28
FRO 42
FR24 35
FR72 35
SynVivR0 21
SynVivR24 14
SynVivR72 21
SynSuspR0 56
SynSuspR24 35
SynSuspR72 35
Mean
70.2
61.4
68.6
86.8
85.2
81.5
53.4
63.8
56.9
87.5
84.3
81.0
Column Std Dev Std. Error
FCR0 9.79 1.999
FCR24 7.30 1.721
FCR72 8.36 1.707
FRO 5.45 0.909
FR24 6.79 1.239
FR72 7.46 1.362
SynVivR0 9.00 2.121
SynVivR24 6.89 1.990
SynVivR72 7.00 1.650
SynSuspR0 5.91 0.853
SynSuspR24 8.19 1.495
SynSuspR72 11.01 2.010
Max
84 3
77 2
87 2
94 6
95 5
96 2
71 4
76 6
68 8
98.3
i00.0
101.2
Column
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SynSuspR24
SynSuspR72
Min
50 5
45 9
56 7
71 2
68 5
61 1
38 1
50 6
42 5
73 5
63.8
56.7
Range
33.8
31.3
30.5
23.4
27.0
35.1
33.3
26.1
26.3
24.8
36.2
44.4
Median
69.8
61.4
71.6
87.3
85.5
80.9
52.7
63.4
58.3
87.4
84.3
80.2
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Insulin, pancreas, ICC
Descriptive Statistics:
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SynSuspR24
SynSuspR72
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SynSuspR24
SynSuspR72
Column
VivCL0
FCR0
FCR24
FCR72
FRO
FR24
FR72
SynVivR0
SynVivR24
SynVivR72
SynSuspR0
SynSuspR24
SynSuspR72
Size
23
25
24
25
22
27
24
26
23
23
55
25
24
Std Dev
9.16
8.12
7.23
6.59
9.90
8.09
6.32
7.43
7.30
6.61
ii.00
7.65
8.10
Max
69 1
66 7
59 9
55 7
71 3
59 2
59 3
62 0
66 7
64 2
66.2
69.3
75.8
Mean
58.8
51.7
47.5
44.9
59.5
42.4
51.0
48.3
54.5
52.7
46.1
56.7
61.3
Std. Error
2.10
1.82
1.66
1.47
2.40
1.72
1.45
1.62
1.72
1.56
1.66
1.71
1.86
Min
43 4
37 7
37 1
31 0
42 7
28 8
34 9
31 7
38.1
42.1
20.6
43.9
44.0
Range
25 7
29 1
22 8
24 7
28 6
30 4
24 4
30 4
28 5
22 1
45 6
25 4
31 8
Median
60.9
52.0
46.9
45.8
64.3
41.6
52.9
47.0
56.0
52.7
44.6
58.0
61.8
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A6
S -Code
IFCI
2FC2
3[FC3
4FC4
5FC5
6FC6
7FC7
8FC8
9FC9
10FCI0
IIFCII
12FC12
13FC13
14FC14
15FC15
16FC16
17IF 1
18F2
19F3
20F4
21F5
22F6
23F7
24F8
25F9
26FI0
27FII
28F12
29F13
30rFl4
31F15
32F16
331/1
34V2
35V3
36_r4
37V5
38V6
39V7
40V8
41V9
42VI0
43_11
44%712
45V13
46_14
K28k-ELISA K28k-ICC S' -Code K9k-ELISA
5. 7992 44.379_FCI : 26 2549
5.8437 50.3239FC2 26.2549
5 2572 51.27441FC3 1-8.5879
5 3259 37. 01211FC4 26/3246
5 4958 29. 2355]FC5 25.3488
7 7772n.d. FC6 33 7825
7 8015 22 3640FC7 -- i0.9906_
7. 0531] 26 3569FC8 ii_1997]
7. 3322 -i-5 9961FC9 28.97321
7 9228 18_3775_FC10 ] 21.3062j
6
6 83471 22_2387]FC13 18. 8667 ]
6.7214 34 3839  c14 30 1581 
: 3.27_ _. 540_1 9.0390
" 3. 8657 78.69971F2 I 17. 8212
• 6. 0095 60.7473F3 14. 9635
4. 5007 55. 122 9F_ - i0. 0845
• 4.52101 _--45,4431F5 12. 5937
4. 8082 62 24831F6 29. 5308
6.0136 31i81 7 29 8096
] 6.6486   .0619iF8 " 28.4853
5 7628 34.7636]:F9 " 24 5124
4 5695 • 36 2686_FI0 2--8 4853
4 7515 30 7326'FII 19 1455
4 9740 34.4122F12 ] 16 7757
I
3 6715 36. 9223 ?13 20. 9577
4 1974 _ 37. 044-0 714 -- 25 6973 ]
-- 6 2644 _ 44_ 1456F15 7- ]_7.6818
] 4 96591 44.0181]F16 -_ - 14.4059 !
7 9956_n:d ..... _l 33 7825
i
i
I
7 00051 4918098_V9 30 5763 !
7 7974!n.d__ 'VI0 ' 32 1097
2i09_n. d_ - Vll _ 17 1339!
5 9367 29'6742V12 34 4795!
7 36861 39.3003Vi3 " 34 06i3 i
6 0985 41.4264_14 ! 33 5037
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A7
47V15
48V16
49V17
50V18
51V19
52V20
53_21
54V22
55SI
56S2
57S3
58S4
59S5
60S6
61S7
62S8
63S9
64Si0
65SII
66S12
67S13
68S14
69S15
70S16
71S17
72S18
73S19
74S20
75S21
7 9875
7 3403[
8 4446
7 4657
6 4019
7
6
9
4
44.8223_15
43 6272_16
32 8965V17
32 2011V18
41 1306V19
9188 39 7683V20
7255
5974
9538
3 9951
4 7879
40 4611_V21
43 5480_V22
67 1326SI
49.8078S2
56.5361S3
4 1124 60.2975]S4
3 4167n. d. S5
3.7605n.d. $8
3 6472n.d. $9
3 9223n.d. SIO
4
5
6
4
4
3
3
2
4
3
4
0153n. d. IS11
1924 53.69621S12
2482 46.9773S13
5371 51.7776S14
7879 57.6177S15
4167 51.4943S16
8333 61.535_S17
3407 63.4326S18
1003 63.5284S19
5340 64.140_$20
5088 70_6381S21
37.7554
30.4369
27.3004
24.8609
16.4272
21.7244
15.5908
43.9587
25.9064
18 5879
23 9548
14 6150
23 3275
ii 4785
6 1116
24 5821
ii 5482
27 5792
23 3972
31 203_
32 7370
40.1949
13.7786
13.7786
25.6973
13.9180
n.d.
n.d.
15.0332
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A8
S" -Code I9k-ELISA I9k- ICC S Code Ins- ICC
IFCI ..... 5 3610n.d. _FCI 50_2167
2FC2 -- 5. 4985[n.d. FC2 44 .3902_
3Fc3 5.3940i 81.4828Fc3 _9_4336'
4FC4 _ 5.1520 _ 62. 4757FC4 In.d.
5FC5 4-833_ 63 7480]]C5 _ 59_8086]
6FC6 41921_ 7312011_ C6 I 45_8674
8jFC8 " 4.3545] 4. 4480.FC8 •
II,FCil 4 1565 68 1 95 •
ISFClS I 1535 8_.458s_Fc15 50.3499
16_c16 0 89s0 84_16921Fc16 47o467{
17F1 3_7o55 89.6685_F1 | 65.1337
20[F4 ] 3.9145 89 .3-5-_4- Un.d.
I
221_6 7 43270_ 79.5008_6 48 3599
23F7 - _ 4.1345 84 7477<F7 39 1610
24F8 1.9950 75 I093F8 37 0330
25F9 ! 3 0785 81.012_F9 48 5472
26F10 _.622_ 82.497_10 _v 67o9
27Fl1• _ 3o2o 88 .9415Fli_ 39 2782
28F12 2 7375 80 0568F12 _ 49 2748]
29F13 3 0785 81 0125F13 51 9748
30F14 2_6220_ 82 49_V_F14 45 2043
31[Fi5 - 1 3020 • 88 94i5_ig _ ....52.9530]
32F16 2 7375 80 6568_16 _ - __._.539826_ J
NAG2-967
40_8 ! 4--2445 _ 4-8.6879_8 i 47-3921i
4179 3 5350!n]dl _9 In.dl - '
437ii 4.51951 62.3034_ii i 52.9083
449i2 i 5o35551 4§?i160_i2 1 5577019
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